The Canadian Bioceutical CBICF

Some common sense points

[horseraddish]

Operational and Financial Highlights for the Fiscal First Quarter of 2019

 

• Total revenues of $14.5 million for the fiscal first quarter of 2019 versus $4.5 million for the fiscal first quarter of 2018 up 224%
• Quarter-Over-Quarter revenue growth of 81% to $14.5 million, up from $8.0 million in the fiscal fourth quarter of 2018
• Opened third Health for Life dispensary in the Phoenix, Arizona metropolitan area
• Completed relocation of Mesa, Arizona processing and production facility to new location in North Mesa, Arizona
• Received final licensing approval from Maryland Medical Cannabis Commission to operate the first dispensary in Maryland under the Health for Life brand. Approval for the opening of two additional dispensaries in Maryland was received subsequent to the quarter end.
• Completed the acquisition of 8423695 Canada Inc., operating as Canveda, a licensed producer in Canada with an existing cultivation and production facility in Peterborough, Ontario

It's obvious there's going to be an increase in revenue and this thing is shaping up with a solid foundation to move higher......its right in front of you
 

[grapejuiceboys]

Couldn't agree more. On a multiples basis, MPX is extremely undervalued... It's strange we aren't seeing much movement with these latest financials - they posted more revenue than Tilray (a +$5B company).

[RetiredGolfer]

Start to finish. Whats is the cost from ground up for a dispensary ?  Do they all have the same amount of staff ?